That was a conclusion that it was possible -- even feasible -- to draw after listening to several of the sessions at the European Generics A...

Finally. The months of waiting are over. (No, we aren’t talking about the Phillies’ attempt to dominate in the National League (it's ...

Bill Clinton, the man who once called drug manufacturers "profiteers" literally in their own territory, got two standing ovations ...

To the chagrin of many, the biggest banks emerged from the recession not just intact but with engines full throttle and little fear of a yel...

We knew there was a reason the Pharmaceutical Research & Manufacturers wanted to hold their annual meeting in Jersey City. New Jersey G...

The Pharmaceutical Research & Manufacturers of America annual meeting kicked off today in Jersey City with the address by Chairman Chris...

The potential impending government shut-down is the top no-deal of the week as Republicans and Dems struggle with the “c” word. (Compromise ...

FDA’s recently published guidance on Post Marketing Studies and Clinical Trials is a study in the importance of the mot juste . The guidance...

For all the new business opportunities China presents in the 21st Century, it's been difficult for start-ups to find a new pharma model ...

Wanted : Senior investor to oversee strategy for one of the largest -- and certainly the oldest -- biopharma corporate venture groups. Bra...